Sign Up to like & get
recommendations!
1
Published in 2022 at "Movement Disorders"
DOI: 10.1002/mds.29273
Abstract: Tau pathology is observed during autopsy in many patients with Parkinson's disease dementia (PDD). Positron emission tomography (PET) imaging using the tracer 18F‐florzolotau has the potential to capture tau accumulation in the living brain.
read more here.
Keywords:
tau;
positron emission;
disease dementia;
parkinson disease ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Movement Disorders"
DOI: 10.1002/mds.29338
Abstract: Recent development in tau‐sensitive tracers has sparkled significant interest in tracking tauopathies using positron emission tomography (PET) biomarkers. However, the ability of 18F‐florzolotau PET imaging to topographically characterize tau pathology in corticobasal syndrome (CBS) remains…
read more here.
Keywords:
positron emission;
pathology;
18f florzolotau;
tau pathology ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Stroke"
DOI: 10.1161/strokeaha.122.040493
Abstract: Background: Studies using animal models have shown that cerebral hypoperfusion causes hyperphosphorylation of tau protein, leading to neuronal damage. However, the relationship between hypoperfusion and tau deposition in humans is unclear. Hence, we aimed to…
read more here.
Keywords:
artery;
tau;
disease;
deposition ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Brain Sciences"
DOI: 10.3390/brainsci12101355
Abstract: Purpose: 18F-Florzolotau is a novel second-generation tau radiotracer that shows higher binding affinity and selectivity and no off-target binding. The proportion loss of functional connectivity strength (PLFCS) is a new indicator for representing brain functional…
read more here.
Keywords:
mci;
brain;
18f florzolotau;
functional connectivity ... See more keywords